Product Details
| Product Name:
(3R,5R)-1-Boc-3,5-diMethylpiperazine |
CAS No.:
438049-91-3 |
| Min. Order:
1KG |
Purity:
95%~99.99% |
| Supply Ability:
10 MT/ Month |
Release date:
2024/10/22 |
Heidi 459
| (3R,5R)-1-Boc-3,5-diMethylpiperazine Basic information |
| Product Name: |
(3R,5R)-1-Boc-3,5-diMethylpiperazine |
| Synonyms: |
(3R,5R)-tert-Butyl 3,5-diMethylpiperazine-1-carboxylate;(3R,5R)-1-Boc-3,5-diMethylpiperazine;tert-Butyl (3R,5R)-3,5-diMethylpiperazine-1-carboxylate;(3R,5R)-3,5-Dimethyl-1-piperazinecarboxylic Acid 1,1-Dimethylethyl Ester;1-Piperazinecarboxylic acid, 3,5-diMethyl-, 1,1-diMethylethyl ester, (3R,5R)- |
| CAS: |
438049-91-3 |
| MF: |
C11H22N2O2 |
| MW: |
214.30458 |
| EINECS: |
|
| Product Categories: |
|
| Mol File: |
438049-91-3.mol |
 |
| |
| (3R,5R)-1-Boc-3,5-diMethylpiperazine Chemical Properties |
| Boiling point |
279.7±15.0 °C(Predicted) |
| density |
0.970±0.06 g/cm3(Predicted) |
| pka |
8.58±0.60(Predicted) |
| |
| (3R,5R)-1-Boc-3,5-diMethylpiperazine Usage And Synthesis |
| Uses |
(3R,5R)-1-Boc-3,5-diMethylpiperazine is used in the preparation of 5HT3 modulators and used in the treatment of CINV and IBS-D. It is also used in the preparation o f 5-HT2 receptors. |
Company Profile Introduction
Technology research and transfer of pilot screening, pilot scale-up and mass production solutions , for pharmaceutical intermediates, biologicals and fine chemicals (Not including inflammable , explosive , hazardous goods ) ; Market : Nano material , metal catalyst , raw material of cosmetics , pharmaceutical intermediates , chemicals , photoelectric material , import and export of technology and goods (For projects subject to approval according to law, business activities can be carried out only after approval by relevant departments ).
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 |
|
|
|
VIP2Y
|
Shanghai Yongzeng Technology Co.,Ltd
|
2026-07-17 |
|
|
$8.00
|
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2026-07-09 |
|
|
|
VIP2Y
|
Shenzhen Nexcon Pharmatechs Ltd.
|
2026-07-09 |
China